全球造影劑市場

預計到 2032 年，全球造影劑市場規模將達到 78 億美元。

全球造影劑市場規模預計在2025年為50億美元，在2025年至2032年的分析期間將以6.4%的複合年成長率成長，到2032年達到78億美元。本報告分析的細分市場之一—「碘基造影劑」—預計將以7.9%的複合年成長率成長，並在分析期結束時達到29億美元。 「钆基造影劑」細分市場預計在整個分析期間內將以5.0%的複合年成長率成長。

美國市場規模估計為 14 億美元，而中國市場預計將以 10.1% 的複合年成長率成長。

據估計，2025年美國造影劑市場規模將達14億美元。作為世界第二大經濟體，中國預計在2025年至2032年的分析期間將以10.1%的複合年成長率成長，到2032年市場規模將達到17億美元。其他值得關注的區域市場包括日本和加拿大，預計在分析期內將分別以3.3%和6.3%的複合年成長率成長。在歐洲，德國預計將以約4.4%的複合年成長率成長。

全球造影劑市場－主要趨勢與促進因素概述

醫學影像造影劑是用於改善疾病診斷影像過程的物質。這些造影劑透過多種方式幫助放射性藥物釋放能量，包括X光、伽馬射線、聲波、無線電波（造影劑）和放射性粒子。透過提高影像對比度，它們使醫護人員能夠更清晰地觀察和評估內部結構，檢測異常情況，並為準確診斷提供關鍵資訊。醫學影像是一項至關重要的工具，它幫助醫生診斷從癌症到中風等各種疾病，挽救了數百萬人的生命。人工智慧（AI）是影響該領域發展的最重要趨勢之一。

醫學影像技術的進步不斷拓展其應用範圍，實現更快、更安全、更有效率的診斷影像。各公司正利用尖端技術和全球公認的安全規範，提供全面的診斷影像解決方案。人工智慧、機器學習和深度學習是推動診斷成像技術進步的關鍵因素。這些技術正被整合到電腦斷層掃描、MRI和超音波診斷中，以近乎完美的精確度自動完成重複性任務，並降低成本，優於傳統方法。醫療專業人員越來越依賴以人工智慧為基礎的解決方案來評估風險並制定個人化治療方案，從而確保提供最佳且經濟高效的醫療服務。虛擬實境（VR）和擴增實境（AR）在3D醫學影像技術中的應用，透過從2D MRI和電腦斷層掃描產生3D影像，提高了醫生對複雜結構的視覺感知能力。儘管VR/AR市場仍在發展中，但其在醫療領域的變革潛力正日益凸顯。

核子醫學掃描術診斷和穿戴式技術也在推動醫學影像的進步。核子醫學掃描術診斷利用放射性示蹤劑來獲取有關癌症和阿茲海默症內部疾病的詳細信息，而「EXPLORER」全身PET/CT掃描儀等設備的出現提高了成像效率。穿戴式科技為放射學帶來了新的應用，例如高清DOT設備和穿戴式超音波掃描儀，能夠持續監測大腦和器官。這些創新拓展了診斷能力，並透過實現早期發現和更有效的治療，為改善患者照護做出了貢獻。

部分：

產品類別（碘基造影劑、钆基造影劑、微氣泡造影劑、鋇基造影劑）、檢查方式（診斷放射性藥物、X光、電腦斷層掃描（CT）、磁振造影（MRI）、超音波及其他檢查方式）、應用領域（腫瘤學、循環系統學、胃腸病學、神經病學及其他應用領域和最終用途（醫院用途）。

大公司

• Aytu BioScience Inc.
• Bayer Healthcare Pharmaceuticals
• Bracco Diagnostics Inc.
• Curium
• Daiichi Sankyo Company Limited
• Eli Lilly
• GE Healthcare
• Guerbet Group
• Lantheus Medical Imaging Inc.
• Piramal Imaging SA

基於領域專家的觀點——融合了來自工業界、商界和學術界專家的觀點，並增加了超越傳統已發表研究的背景。

我們捕捉早期市場訊號——追蹤專家對話、公司趨勢和市場相關討論中出現的變化，而這些變化尚未完全反映在傳統的二級研究中。

我們利用廣泛且檢驗的資訊基礎設施，整合了來自會議、主題演講、專題研討會、部落格、公司資訊披露、年度報告、機構出版物和其他檢驗的資訊來源的見解。

我們將訊號與策略市場方向連結起來—整合這些觀點，以確定市場走向、推動市場發展的因素以及哪些趨勢可能對您的策略最為重要。

我們提供詳細的企業資料——不僅是市場層級的分析，而且是對參與和促成競爭環境形成的公司進行徹底的考察。

深入剖析關鍵區域的市佔率－單一的全球市佔率數據往往難以提供全貌。不同區域的競爭格局可能有顯著差異。在分析需求時，Market Glass 的報告會根據各市場的結構和趨勢調整分析的詳細程度，深入剖析關鍵區域的市場佔有率。

目錄

第1章：調查方法

第2章執行摘要

• 市場概覽
• 大公司
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 亞太其他地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東國家
• 非洲

第4章 競賽

Global Imaging Agents Market to Reach US$7.8 Billion by 2032

The global market for Imaging Agents estimated at US$5.0 Billion in the year 2025, is expected to reach US$7.8 Billion by 2032, growing at a CAGR of 6.4% over the analysis period 2025-2032. Iodinated Contrast Media Offering, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Gadolinium-based Contrast Media Offering segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 10.1% CAGR

The Imaging Agents market in the U.S. is estimated at US$1.4 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2032 trailing a CAGR of 10.1% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Imaging Agents Market - Key Trends and Drivers Summarized

Diagnostic imaging agents, or contrast agents, are substances administered to patients to enhance the imaging process for disease diagnosis. These agents help radiopharmaceuticals emit energy using various methods, such as X-rays, gamma rays, sound waves, radio waves (MRI), and radioactive particles. By improving image contrast, they enable healthcare professionals to better visualize and assess body structures and detect abnormalities, providing critical insights for accurate diagnosis. Medical imaging is a critical tool that saves millions of lives by helping doctors diagnose diseases ranging from cancer to stroke. One of the most influential trends shaping this field is artificial intelligence (AI).

Technological progress in medical imaging continues to expand possibilities, leading to faster, safer, and more efficient imaging. Companies leverage advanced technology and globally accepted safety protocols to offer comprehensive imaging solutions. Key drivers in imaging advancements include AI, machine learning, and deep learning. These technologies are integrated into CT scans, MRIs, and ultrasounds to automate repetitive tasks with nearly perfect accuracy, cutting costs compared to traditional methods. Healthcare professionals increasingly rely on AI-based solutions to assess risk and tailor treatments, ensuring optimal, cost-effective therapy. Virtual and augmented reality (VR/AR) in 3D medical imaging technologies provide physicians with enhanced visualization of complex structures by creating 3D images from 2D MRI or CT scans. While the VR/AR market is still developing, its transformative potential in healthcare is becoming evident.

Nuclear imaging and wearable technology are also driving advancements in medical imaging. Nuclear imaging uses radiotracers to provide detailed insights into internal conditions such as cancer and Alzheimer's disease, with devices like the EXPLORER Total-body PET/CT Scanner improving efficiency. Wearables offer new applications in radiology, with the HD-DOT instrument and wearable ultrasound scanners enabling continuous brain and organ monitoring. These innovations are expanding diagnostic capabilities and improving patient care by providing earlier detection and more effective treatments.

SCOPE OF STUDY:

The report analyzes the Imaging Agents market by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering, Barium-based Contrast Media Offering); Modality (Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality, Other Modalities); Application (Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Aytu BioScience Inc.
• Bayer Healthcare Pharmaceuticals
• Bracco Diagnostics Inc.
• Curium
• Daiichi Sankyo Company Limited
• Eli Lilly
• GE Healthcare
• Guerbet Group
• Lantheus Medical Imaging Inc.
• Piramal Imaging SA

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Global Economic Update
  • Imaging Agents - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 23 Players Worldwide in 2026 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Chronic Diseases Drives Demand for Enhanced Diagnostic Imaging
  • Nanotechnology Innovations Open New Frontiers in Imaging Agent Efficacy
  • Expansion of Personalized Medicine Strengthens the Business Case for Targeted Imaging Agents
  • Aging Global Population Increases Utilization of Imaging Services
  • Technological Advancements in Imaging Equipment Spur Demand for Compatible Agents
  • Safety Concerns and Side Effects Prompt Research into Alternative Imaging Agents
  • Rise of Theranostics Integrates Diagnostic and Therapeutic Capabilities in Single Agents
  • Growing Healthcare Expenditure Worldwide Expands Addressable Market for Imaging Agents
  • Emergence of Multi-modal Imaging Techniques Catalyzes Innovations in Agent Development
  • Shift Towards Minimally Invasive Procedures Enhances the Role of Imaging Agents
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Imaging Agents Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • TABLE 2: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 3: World Historic Review for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 4: World 13-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • TABLE 5: World Recent Past, Current & Future Analysis for Iodinated Contrast Media Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 6: World Historic Review for Iodinated Contrast Media Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 7: World 13-Year Perspective for Iodinated Contrast Media Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 8: World Recent Past, Current & Future Analysis for Gadolinium-based Contrast Media Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 9: World Historic Review for Gadolinium-based Contrast Media Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 10: World 13-Year Perspective for Gadolinium-based Contrast Media Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 11: World Recent Past, Current & Future Analysis for Microbubble Contrast Media Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 12: World Historic Review for Microbubble Contrast Media Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 13: World 13-Year Perspective for Microbubble Contrast Media Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 14: World Recent Past, Current & Future Analysis for Barium-based Contrast Media Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 15: World Historic Review for Barium-based Contrast Media Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 16: World 13-Year Perspective for Barium-based Contrast Media Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 18: World Historic Review for Diagnostic Radiopharmaceuticals Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 19: World 13-Year Perspective for Diagnostic Radiopharmaceuticals Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 20: World Recent Past, Current & Future Analysis for X-ray Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 21: World Historic Review for X-ray Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 22: World 13-Year Perspective for X-ray Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 23: World Recent Past, Current & Future Analysis for Computed Tomography Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 24: World Historic Review for Computed Tomography Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 25: World 13-Year Perspective for Computed Tomography Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 26: World Recent Past, Current & Future Analysis for Magnetic Resonance Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 27: World Historic Review for Magnetic Resonance Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 28: World 13-Year Perspective for Magnetic Resonance Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 29: World Recent Past, Current & Future Analysis for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 30: World Historic Review for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 31: World 13-Year Perspective for Ultrasound Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 33: World Historic Review for Other Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 34: World 13-Year Perspective for Other Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 35: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 36: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 37: World 13-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 38: World Recent Past, Current & Future Analysis for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 39: World Historic Review for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 40: World 13-Year Perspective for Cardiology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 41: World Recent Past, Current & Future Analysis for Gastrointestinal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 42: World Historic Review for Gastrointestinal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 43: World 13-Year Perspective for Gastrointestinal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 44: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 45: World Historic Review for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 46: World 13-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 47: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 48: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 49: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 50: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 51: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 52: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 53: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 54: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 55: World 13-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 56: World Recent Past, Current & Future Analysis for Diagnostic & Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 57: World Historic Review for Diagnostic & Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 58: World 13-Year Perspective for Diagnostic & Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 59: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 60: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 61: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

• UNITED STATES
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • TABLE 62: USA Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 63: USA Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 64: USA 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 65: USA Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 66: USA Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 67: USA 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 68: USA Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 69: USA Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 70: USA 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 71: USA Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 72: USA Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 73: USA 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 75: Canada Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 76: Canada 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 78: Canada Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 79: Canada 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 81: Canada Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 82: Canada 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 84: Canada Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 85: Canada 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• JAPAN
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 87: Japan Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 88: Japan 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 90: Japan Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 91: Japan 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 93: Japan Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 94: Japan 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 96: Japan Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 97: Japan 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• CHINA
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • TABLE 98: China Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 99: China Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 100: China 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 101: China Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 102: China Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 103: China 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 104: China Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 105: China Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 106: China 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 107: China Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 108: China Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 109: China 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• EUROPE
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 111: Europe Historic Review for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 112: Europe 13-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 114: Europe Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 115: Europe 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 117: Europe Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 118: Europe 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 120: Europe Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 121: Europe 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 123: Europe Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 124: Europe 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• FRANCE
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • TABLE 125: France Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 126: France Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 127: France 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 128: France Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 129: France Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 130: France 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 131: France Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 132: France Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 133: France 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 134: France Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 135: France Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 136: France 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• GERMANY
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 138: Germany Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 139: Germany 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 141: Germany Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 142: Germany 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 144: Germany Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 145: Germany 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 147: Germany Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 148: Germany 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ITALY
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 150: Italy Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 151: Italy 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 153: Italy Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 154: Italy 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 156: Italy Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 157: Italy 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 159: Italy Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 160: Italy 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• UNITED KINGDOM
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • TABLE 161: UK Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 162: UK Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 163: UK 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 164: UK Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 165: UK Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 166: UK 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 167: UK Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 168: UK Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 169: UK 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 170: UK Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 171: UK Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 172: UK 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SPAIN
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 174: Spain Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 175: Spain 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 177: Spain Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 178: Spain 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 180: Spain Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 181: Spain 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 183: Spain Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 184: Spain 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• RUSSIA
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 186: Russia Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 187: Russia 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 189: Russia Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 190: Russia 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 192: Russia Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 193: Russia 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 195: Russia Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 196: Russia 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF EUROPE
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 199: Rest of Europe 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 202: Rest of Europe 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 205: Rest of Europe 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 208: Rest of Europe 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ASIA-PACIFIC
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 211: Asia-Pacific 13-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 214: Asia-Pacific 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 217: Asia-Pacific 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 220: Asia-Pacific 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 223: Asia-Pacific 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• AUSTRALIA
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 225: Australia Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 226: Australia 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 228: Australia Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 229: Australia 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 231: Australia Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 232: Australia 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 234: Australia Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 235: Australia 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• INDIA
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
  • TABLE 236: India Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 237: India Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 238: India 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 239: India Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 240: India Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 241: India 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 242: India Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 243: India Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 244: India 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 245: India Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 246: India Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 247: India 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SOUTH KOREA
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 249: South Korea Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 250: South Korea 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 252: South Korea Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 253: South Korea 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 255: South Korea Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 256: South Korea 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 258: South Korea Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 259: South Korea 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF ASIA-PACIFIC
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• LATIN AMERICA
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 273: Latin America Historic Review for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 274: Latin America 13-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 276: Latin America Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 277: Latin America 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 279: Latin America Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 280: Latin America 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 282: Latin America Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 283: Latin America 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 285: Latin America Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 286: Latin America 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ARGENTINA
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 288: Argentina Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 289: Argentina 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 291: Argentina Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 292: Argentina 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 294: Argentina Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 295: Argentina 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 297: Argentina Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 298: Argentina 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• BRAZIL
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 300: Brazil Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 301: Brazil 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 303: Brazil Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 304: Brazil 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 306: Brazil Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 307: Brazil 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 309: Brazil Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 310: Brazil 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• MEXICO
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 312: Mexico Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 313: Mexico 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 315: Mexico Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 316: Mexico 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 318: Mexico Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 319: Mexico 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 321: Mexico Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 322: Mexico 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF LATIN AMERICA
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 325: Rest of Latin America 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 328: Rest of Latin America 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 331: Rest of Latin America 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 334: Rest of Latin America 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• MIDDLE EAST
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 336: Middle East Historic Review for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 337: Middle East 13-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 339: Middle East Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 340: Middle East 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 342: Middle East Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 343: Middle East 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 345: Middle East Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 346: Middle East 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 348: Middle East Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 349: Middle East 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• IRAN
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 351: Iran Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 352: Iran 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 354: Iran Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 355: Iran 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 357: Iran Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 358: Iran 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 360: Iran Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 361: Iran 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ISRAEL
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 363: Israel Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 364: Israel 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 366: Israel Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 367: Israel 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 369: Israel Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 370: Israel 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 372: Israel Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 373: Israel 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SAUDI ARABIA
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 376: Saudi Arabia 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 379: Saudi Arabia 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 382: Saudi Arabia 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 385: Saudi Arabia 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• UNITED ARAB EMIRATES
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 387: UAE Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 388: UAE 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 390: UAE Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 391: UAE 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 393: UAE Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 394: UAE 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 396: UAE Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 397: UAE 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF MIDDLE EAST
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 400: Rest of Middle East 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 403: Rest of Middle East 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 406: Rest of Middle East 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 409: Rest of Middle East 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• AFRICA
  • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 411: Africa Historic Review for Imaging Agents by Offering - Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 412: Africa 13-Year Perspective for Imaging Agents by Offering - Percentage Breakdown of Value Sales for Iodinated Contrast Media Offering, Gadolinium-based Contrast Media Offering, Microbubble Contrast Media Offering and Barium-based Contrast Media Offering for the Years 2020, 2026 & 2032
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 414: Africa Historic Review for Imaging Agents by Modality - Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 415: Africa 13-Year Perspective for Imaging Agents by Modality - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals Modality, X-ray Modality, Computed Tomography Modality, Magnetic Resonance Imaging Modality, Ultrasound Modality and Other Modalities for the Years 2020, 2026 & 2032
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 417: Africa Historic Review for Imaging Agents by Application - Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 418: Africa 13-Year Perspective for Imaging Agents by Application - Percentage Breakdown of Value Sales for Oncology Application, Cardiology Application, Gastrointestinal Application, Neurology Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 420: Africa Historic Review for Imaging Agents by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 421: Africa 13-Year Perspective for Imaging Agents by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic & Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032

IV. COMPETITION